Stock Market News

1 week AbbVie Stock Falls 11% in a Month: Should You Buy the Dip?Zacks

Investors who own ABBV stock may stay invested as the company has faced its biggest challenge quite well and looks set to return to robust growth next year.

AbbVie (ABBV)

12 hours Are Hedge Funds Betting Big On AbbVie Inc. (ABBV)?Insider Monkey X

1 day AbbVie: Upgrading To ‘Strong Buy’ After PullbackSeeking Alpha X

1 day Trade Tracker: Jim Lebenthal buys more AbbvieYouTube X

1 day AbbVie Jumps 5% On An Upgrade Despite Bristol Myers-Tied SetbackInvestor's Business Daily X

1 day AbbVie, Nvidia Lead Friday’s Market Cap Stock MoversInvesting.com X

4 days Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?Zacks X

4 days Where Will AbbVie Be in 5 Years?Yahoo Finance X

4 days Where Will AbbVie Be in 5 Years?The Motley Fool X

5 days AbbVie’s Ovarian Cancer Drug Elahere Gets Approval in EuropeZacks X

6 days Why This Beaten-Down Dividend Stock Is a No-Brainer Buy on the DipThe Motley Fool X

1 week Dividend King AbbVie Just Paid Investors: Here’s How Much They Got24/7 Wall St. X

1 week Pharma Stock Roundup: AZN, BAYRY’s Earnings, ABBV’s Pipeline SetbackZacks X

1 week Got $1,500 to Invest? AbbVie Just Proved the Bull Thesis for Its StockThe Motley Fool X

1 week Final Trades: Bitcoin, Abbvie and Baker HughesYouTube X

1 week Aldeyra’s FDA Resubmission And AbbVie Option Revitalize Reproxalap’s ProspectsSeeking Alpha X

2 weeks AbbVie’s Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology PortfolioYahoo Finance X

2 weeks Final Trades: Lyft, Meta, United States Oil Fund & AbbvieYouTube X

2 weeks AbbVie And Pfizer: Q3 Dividend Checkup Post-EarningsSeeking Alpha X

2 weeks Is AbbVie Still A Strong Buy After Fantastic Gains? (Rating Downgrade)Seeking Alpha X

2 weeks AbbVie Stock: Keep Calm And Buy The DipSeeking Alpha X

2 weeks Why AbbVie Stock Was Getting Mashed on MondayThe Motley Fool X

2 weeks Bristol Rockets 11% As Investors Question AbbVie’s $8.7 Billion ‘Mistake’Investor's Business Daily X

2 weeks AbbVie Tumbles After New Schizophrenia Drug Fails Two TrialsYahoo Finance X

2 weeks RHHBY or ABBV: Which Is the Better Value Stock Right Now?Zacks X

3 weeks Analyst Report: AbbVie IncYahoo Finance X

3 weeks Market Digest: THRM, DINO, KLAC, OKE, RJF, SYK, META, ABBV, NCLHYahoo Finance X

3 weeks Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY’s Q3 Earnings in FocusZacks X

3 weeks AbbVie (NYSE:ABBV) Releases Quarterly Earnings Results, Beats Estimates By $0.08 EPSMarketBeat X

3 weeks AbbVie: 3 Positives From The Earnings ReportSeeking Alpha X

3 weeks AbbVie Inc. (NYSE:ABBV) Short Interest Up 8.9% in OctoberMarketBeat X

3 weeks AbbVie (ABBV) Q3 2024 Earnings Call TranscriptThe Motley Fool X

3 weeks AbbVie Trumps Q3 Earnings & Sales Estimates, Raises ’24 EPS ViewZacks X

3 weeks AbbVie (NYSE:ABBV) Stock Price Up 3.2% After Dividend AnnouncementMarketBeat X

4 weeks Compared to Estimates, AbbVie (ABBV) Q3 Earnings: A Look at Key MetricsZacks X

4 weeks AbbVie raises 2024 profit forecast on strong sales of key drugs Skyrizi, RinvoqInvesting.com X

4 weeks AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter BeatInvestor's Business Daily X

4 weeks Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts?Zacks X

4 weeks AbbVie (NYSE:ABBV) Shares Up 1.1% After Analyst UpgradeMarketBeat X

4 weeks First American Bank Cuts Stake in AbbVie Inc. (NYSE:ABBV)MarketBeat X

4 weeks Hamlin Capital Management LLC Buys 76,218 Shares of AbbVie Inc. (NYSE:ABBV)MarketBeat X

4 weeks Mediolanum International Funds Ltd Reduces Stock Position in AbbVie Inc. (NYSE:ABBV)MarketBeat X

4 weeks Final Trades: Tesla, Sweetgreen, AbbVie and Digital RealtyYouTube X

1 month AbbVie (ABBV) Outperforms Broader Market: What You Need to KnowZacks X

1 month AbbVie (NYSE:ABBV) Stock Price Up 1% – What’s Next?MarketBeat X

1 month Private Advisor Group LLC Reduces Stock Position in AbbVie Inc. (NYSE:ABBV)MarketBeat X

1 month Beat the Nasdaq With This Cash-Gushing Dividend StockThe Motley Fool X

1 month AbbVie (NYSE:ABBV) Stock Price Down 0% – Here’s What HappenedMarketBeat X

1 month Foundations Investment Advisors LLC Has $12.81 Million Position in AbbVie Inc. (NYSE:ABBV)MarketBeat X

1 month AbbVie: Strong Dividends But Humira DisappointsSeeking Alpha X

1 month The Zacks Analyst Blog Highlights Johnson & Johnson, Pfizer, Roche, AbbVie and SanofiZacks X